Pharmacokinetic Profile of Dalbavancin in Complicated Bacteremia Caused by Staphylococcus aureus: A Secondary Analysis - Quiz - MDSpire

Pharmacokinetic Profile of Dalbavancin in Complicated Bacteremia Caused by Staphylococcus aureus: A Secondary Analysis

  • By

  • Thomas P. Lodise

  • Nicholas A. Turner

  • Toshimitsu Hamasaki

  • Nick Fishbane

  • Varduhi Ghazaryan

  • Alison Wall

  • Lizhao Ge

  • Qihang Wu

  • Lijuan Zeng

  • Todd Riccobene

  • Rinal Patel

  • Smitha Zaharoff

  • Urania Rappo

  • Scott Evans

  • Vance G. Fowler

  • Henry F. Chambers

  • Thomas L. Holland

  • Antibacterial Resistance Leadership Group

  • Robin Patel

  • Heather Cross

  • Anthony Harris

  • Melinda Pettigrew

  • David van Duin

  • Helen Boucher

  • Clayton Huntley

  • Erica Raterman

  • Tamika Samuel

  • Kyung Moon

  • Kim Hanson

  • Yohei Doi

  • Tom Lodise

  • Ritu Banerjee

  • Sara Cosgrove

  • David Paterson

  • Ebbing Lautenbach

  • Maureen Mehigan

  • Sarah Doernberg

  • Sam Perdue

  • April 18, 2026

  • 0 min

Share

Original Source(s)

Pharmacokinetic Profile of Dalbavancin in Complicated Bacteremia Caused by Staphylococcus aureus: A Secondary Analysis

  • by Thomas P. Lodise, Nicholas A. Turner, Toshimitsu Hamasaki, Nick Fishbane, Varduhi Ghazaryan, Alison Wall, Lizhao Ge, Qihang Wu, Lijuan Zeng, Todd Riccobene, Rinal Patel, Smitha Zaharoff, Urania Rappo, Scott Evans, Vance G. Fowler, Henry F. Chambers, Thomas L. Holland, Antibacterial Resistance Leadership Group, Robin Patel, Heather Cross, Anthony Harris, Melinda Pettigrew, David van Duin, Helen Boucher, Clayton Huntley, Erica Raterman, Tamika Samuel, Kyung Moon, Kim Hanson, Yohei Doi, Tom Lodise, Ritu Banerjee, Sara Cosgrove, David Paterson, Ebbing Lautenbach, Maureen Mehigan, Sarah Doernberg, Sam Perdue

  • April 18, 2026

Related Content

Synthetic short peptide mimicking IsdB and IsdH conserved motifs selectively bind and enable detection of Staphylococcus aureus infection

Biogenic Caralluma sinaica-derived silver nanoparticles as a synergistic antibacterial and osteoinductive nanoplatform for osteomyelitis management

When Obesity Meets Infection Risk

Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.